this preliminary report of a 6-week , double-blind , placebo-controlled study of the mao inhibitor isocarboxazid ( marplan ) examines the time course of platelet mao inhibition and treatment response , and describes symptoms that distinguish markedly improved from slightly improved responders .
C0022154
isocarboxazid
C0591755
marplan